TI:GER Team Bioletics Aids Diabetics

Team Bioletics presenting during a recent competition

“We are in the business of treating diabetes,” says Maggie Lovatt, member of ACTSI/TI:GER-supported team Bioletics. Lovatt’s team created a device that eliminates the need for insulin by using electrical stimulation. There are nearly 30 million people in the U.S. who have diabetes, some of which inject insulin three to five times daily. Bioletics’ invention sits under the skin and gives the body signals to absorb or release glucose.

Bioletics is a team stemming from Georgia Institute of Technology’s TI:GER program which assembles students into competitive teams of two MBA students, two law students, and a PhD student in order to address the issues that arise in technology commercialization, like patent drafting and law, and maximizing commercial potential. ACTSI supported TI:GER teams in the past by funding travel, tuition, and student stipends. In June 2015, ACTSI awarded the TI:GER program $40,600 for one year.

Already the team has won the Edison Award at the 2015 Georgia Tech Startup Competition presented by VentureLab and sponsored by Georgia Tech’s Scheller College of Business. In addition to the $15,000 cash prize, the win also qualified Bioletics to participate at Startup Madness in Raleigh, NC where they took third place.

“Throughout this process we learned a lot about customer discovery and how to uncover ‘pain points’ with the customer that you can potentially solve,” says Lovatt. “We’ve also made it through three semesters working with an interdisciplinary team. It’s not always easy communicating with people who think differently than you. I was constantly surprised by the way our PhD and JDs approached a problem, just because it was so different than how I see things. I feel very fortunate to have had this experience. I’ve also definitely had my eyes opened to how vibrant the technology startup community is in Atlanta”

Team Bioletics includes Georgia Tech Neural Engineering PhD student Yogi Patel, Georgia Tech MBA students Maggie Lovatt and Hassan El Majidi, and Emory Law students Mark Luo and Sarika Mathur.

The ACTSI is a city-wide partnership between Emory, Morehouse School of Medicine, and Georgia Tech and is one of a national consortium striving to improve the way biomedical research is conducted across the country. The consortium, funded through the National Center for Advancing Translational Sciences one of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA), shares a common vision to translate laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train the next generation of clinical investigators.

Upcoming Events

View All Events

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?

 

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?